Articles

Type 2 MI and Myocardial Injury in the Era of High-sensitivity Troponin

Published:

17 February 2022

Citation:

European Cardiology Review 2022;17:e03.

Valvular Heart Disease in Patients with Chronic Kidney Disease

Published:

31 January 2022

Citation:

European Cardiology Review 2022;17:e02

The 2021 European Heart Failure Guidelines

Published:

28 January 2022

Citation:

European Cardiology Review 2022;17:e01.

The Natural Product Zerumbone Suppresses Pressure Overload-Induced Cardiac Dysfunction by Inhibiting Cardiac Hypertrophy and Fibrosis

Published:

14 December 2021

Citation:

European Cardiology Review 2021;16:e70.

25th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy

Published:

14 December 2021

Citation:

European Cardiology Review 2021;16:e56.

Early Initiation of Tolvaptan is Associated with Early Discharge in Elderly Heart Failure Patients

Published:

14 December 2021

Citation:

European Cardiology Review 2021;16:e67.

A Novel Curcumin Formulation, ASD-Cur, Suppressed the Development of Systolic Dysfunction After Myocardial Infarction in Rats

Published:

14 December 2021

Citation:

European Cardiology Review 2021;16:e69.

Retrospective Study to Assess the Effect of Telmisartan on Urine Albumin to Creatinine Ratio in Indian Hypertensive Patients

Published:

14 December 2021

Citation:

European Cardiology Review 2021;16:e63.

Prevalence of Aspirin and Clopidogrel Resistance in Patients with Recurrent Ischaemic Cerebrovascular Disease

Published:

14 December 2021

Citation:

European Cardiology Review 2021;16:e72.

The Role of Isocitrate Dehydrogenases in Direct Reprogramming to Cardiomyocytes

Published:

14 December 2021

Citation:

European Cardiology Review 2021;16:e64.